Washington Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$516K Buy
4,380
+1,580
+56% +$221K 0.44% 78
2025
Q4
$459K Hold
2,800
0.37% 80
2025
Q3
$374K Buy
+2,800
New +$340K 0.27% 100

Other funds holding RGEN

Washington Capital Management's RGEN Position: Q1 2026 in Review

Washington Capital Management increased its Repligen (RGEN) stake by 56% in Q1 2026, buying an estimated $221K and bringing the position to 4,380 shares worth $516K. The position accounts for 0.44% of the portfolio, ranked #78.

Washington Capital Management first reported a position in RGEN in Q3 2025 and has held it in 3 quarters since. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Washington Capital Management held 4,380 shares of Repligen worth $516K as of Q1 2026.
  • Washington Capital Management bought 1,580 Repligen shares in Q1 2026, an estimated $221K.
  • Repligen made up 0.44% of Washington Capital Management's portfolio in Q1 2026, its #78 holding.
  • Washington Capital Management first reported a position in Repligen in Q3 2025 and has held it in 3 quarters since.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Washington Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.